tiprankstipranks
Quest Diagnostics (MX:DGX)
NYSE:DGX
Mexico Market
DGX
Quest Diagnostics
RESEARCH TOOLSreports

Quest Diagnostics (DGX) Stock Forecast & Price Target

― Followers
See the Price Targets and Ratings of:

DGX Analyst Ratings

Moderate Buy
10Ratings
Moderate Buy
6 Buy
4 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Quest
Diagnostics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DGX Stock 12 Month Forecast

Average Price Target

$4,351.92
Based on 10 Wall Street analysts offering 12 month price targets for Quest Diagnostics in the last 3 months. The average price target is $4,351.92 with a high forecast of $4,639.84 and a low forecast of $3,851.95. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3077":"$3,077","4640":"$4,640","3467.75":"$3,467.8","3858.5":"$3,858.5","4249.25":"$4,249.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4639.84312205,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$4.64K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4351.919942987778,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.35K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3851.9452334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.85K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3077,3467.75,3858.5,4249.25,4640],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3454.853,3546.0060863115386,3637.1591726230768,3728.3122589346153,3819.465345246154,3910.618431557692,4001.7715178692306,4092.924604180769,4184.077690492308,4275.230776803846,4366.383863115385,4457.536949426923,4548.690035738461,{"y":4639.84312205,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3454.853,3523.8581494605983,3592.8632989211965,3661.868448381795,3730.8735978423933,3799.8787473029915,3868.8838967635897,3937.889046224188,4006.8941956847866,4075.899345145385,4144.904494605983,4213.909644066582,4282.914793527179,{"y":4351.919942987778,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3454.853,3485.3985564153845,3515.9441128307694,3546.489669246154,3577.0352256615383,3607.5807820769232,3638.1263384923077,3668.671894907692,3699.2174513230766,3729.7630077384615,3760.308564153846,3790.8541205692304,3821.3996769846153,{"y":3851.9452334,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3282.649,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3078.635,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3328.12,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3371.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3405.298,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3395.427,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3158.537,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3301.591,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3301.591,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3625.801,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3982.54,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3269.785,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3454.853,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$4,640Average Price Target$4,352Lowest Price Target$3,852
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:DGX
Erin Wright
Morgan Stanley
Morgan Stanley
$3,957→$4,552.3
Buy
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (NASDAQ: ZVRA), Roche Holding AG (Other OTC: RHHVF) and Quest Diagnostics (NYSE: DGX)
Truist Financial Analyst forecast on MX:DGX
David S Macdonald
Truist Financial
Truist Financial
$3,939.49→$4,377.21
Hold
―
Reiterated
07/24/26
Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX)
Mizuho Securities Analyst forecast on MX:DGX
Ann Hynes
Mizuho Securities
Mizuho Securities
$4,114.58→$4,552.3
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $260 from $235 at MizuhoQuest Diagnostics price target raised to $260 from $235 at Mizuho
Robert W. Baird Analyst forecast on MX:DGX
Eric Coldwell
Robert W. Baird
Robert W. Baird
$4,132.09→$4,464.75
Hold
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $255 from $236 at BairdQuest Diagnostics price target raised to $255 from $236 at Baird
UBS Analyst forecast on MX:DGX
Kevin Caliendo
UBS
UBS
$3,851.95→$4,062.05
Hold
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Quest Diagnostics (NYSE: DGX)
Barclays Analyst forecast on MX:DGX
Luke Sergott
Barclays
Barclays
$4,027.03→$4,377.21
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $250 from $230 at BarclaysQuest Diagnostics price target raised to $250 from $230 at Barclays
Bank of America Securities Analyst forecast on MX:DGX
Michael Ryskin
Bank of America Securities
Bank of America Securities
$4,639.84
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $265 from $245 at BofAQuest Diagnostics price target raised to $265 from $245 at BofA
Jefferies Analyst forecast on MX:DGX
Tycho Peterson
Jefferies
Jefferies
$3,939.49→$4,289.67
Buy
―
Reiterated
07/23/26
Quest Diagnostics price target raised to $245 from $225 at JefferiesQuest Diagnostics price target raised to $245 from $225 at Jefferies
William Blair Analyst forecast on MX:DGX
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/23/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX) and MindWalk Holdings (NASDAQ: HYFT)
J.P. Morgan Analyst forecast on MX:DGX
Lisa Gill
J.P. Morgan
J.P. Morgan
$3,851.95
Hold
―
Reiterated
05/06/26
Evercore ISI Analyst forecast on MX:DGX
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$3,676.86
Hold
―
Reiterated
04/20/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), Centessa Pharmaceuticals (NASDAQ: CNTA) and Perspective Therapeutics (NYSE MKT: CATX)
Citi Analyst forecast on MX:DGX
Patrick B Donnelly
Citi
Citi
$3,326.68→$3,764.4
Hold
―
Reiterated
02/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)
Piper Sandler Analyst forecast on MX:DGX
David Westenberg
Piper Sandler
Piper Sandler
$3,326.68→$3,501.77
Hold
―
Reiterated
10/27/25
Quest Diagnostics price target raised to $200 from $190 at Piper SandlerQuest Diagnostics price target raised to $200 from $190 at Piper Sandler
Leerink Partners Analyst forecast on MX:DGX
Michael Cherny
Leerink Partners
Leerink Partners
$3,554.29→$3,676.86
Buy
―
Reiterated
10/22/25
Quest Diagnostics price target raised to $210 from $203 at LeerinkQuest Diagnostics price target raised to $210 from $203 at Leerink
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:DGX
Erin Wright
Morgan Stanley
Morgan Stanley
$3,957→$4,552.3
Buy
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (NASDAQ: ZVRA), Roche Holding AG (Other OTC: RHHVF) and Quest Diagnostics (NYSE: DGX)
Truist Financial Analyst forecast on MX:DGX
David S Macdonald
Truist Financial
Truist Financial
$3,939.49→$4,377.21
Hold
―
Reiterated
07/24/26
Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX)
Mizuho Securities Analyst forecast on MX:DGX
Ann Hynes
Mizuho Securities
Mizuho Securities
$4,114.58→$4,552.3
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $260 from $235 at MizuhoQuest Diagnostics price target raised to $260 from $235 at Mizuho
Robert W. Baird Analyst forecast on MX:DGX
Eric Coldwell
Robert W. Baird
Robert W. Baird
$4,132.09→$4,464.75
Hold
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $255 from $236 at BairdQuest Diagnostics price target raised to $255 from $236 at Baird
UBS Analyst forecast on MX:DGX
Kevin Caliendo
UBS
UBS
$3,851.95→$4,062.05
Hold
―
Reiterated
07/24/26
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Quest Diagnostics (NYSE: DGX)
Barclays Analyst forecast on MX:DGX
Luke Sergott
Barclays
Barclays
$4,027.03→$4,377.21
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $250 from $230 at BarclaysQuest Diagnostics price target raised to $250 from $230 at Barclays
Bank of America Securities Analyst forecast on MX:DGX
Michael Ryskin
Bank of America Securities
Bank of America Securities
$4,639.84
Buy
―
Reiterated
07/24/26
Quest Diagnostics price target raised to $265 from $245 at BofAQuest Diagnostics price target raised to $265 from $245 at BofA
Jefferies Analyst forecast on MX:DGX
Tycho Peterson
Jefferies
Jefferies
$3,939.49→$4,289.67
Buy
―
Reiterated
07/23/26
Quest Diagnostics price target raised to $245 from $225 at JefferiesQuest Diagnostics price target raised to $245 from $225 at Jefferies
William Blair Analyst forecast on MX:DGX
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/23/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX) and MindWalk Holdings (NASDAQ: HYFT)
J.P. Morgan Analyst forecast on MX:DGX
Lisa Gill
J.P. Morgan
J.P. Morgan
$3,851.95
Hold
―
Reiterated
05/06/26
Evercore ISI Analyst forecast on MX:DGX
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$3,676.86
Hold
―
Reiterated
04/20/26
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (NYSE: DGX), Centessa Pharmaceuticals (NASDAQ: CNTA) and Perspective Therapeutics (NYSE MKT: CATX)
Citi Analyst forecast on MX:DGX
Patrick B Donnelly
Citi
Citi
$3,326.68→$3,764.4
Hold
―
Reiterated
02/11/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Biogen (NASDAQ: BIIB) and Quest Diagnostics (NYSE: DGX)
Piper Sandler Analyst forecast on MX:DGX
David Westenberg
Piper Sandler
Piper Sandler
$3,326.68→$3,501.77
Hold
―
Reiterated
10/27/25
Quest Diagnostics price target raised to $200 from $190 at Piper SandlerQuest Diagnostics price target raised to $200 from $190 at Piper Sandler
Leerink Partners Analyst forecast on MX:DGX
Michael Cherny
Leerink Partners
Leerink Partners
$3,554.29→$3,676.86
Buy
―
Reiterated
10/22/25
Quest Diagnostics price target raised to $210 from $203 at LeerinkQuest Diagnostics price target raised to $210 from $203 at Leerink
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
ENOVEnovis
GKOSGlaukos
IFRXInflaRx
BKDBrookdale Senior Living
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Quest Diagnostics

3 Months
Michael RyskinBank of America Securities
Success Rate
11/12 ratings generated profit
92%
Average Return
+5.98%
Copying Michael Ryskin's trades and holding each position for 3 Months would result in 91.67% of your transactions generating a profit, with an average return of +5.98% per trade.
1 Year
Michael ChernyLeerink Partners
Success Rate
8/8 ratings generated profit
100%
Average Return
+23.40%
Copying Michael Cherny's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.40% per trade.
2 Years
Michael RyskinBank of America Securities
Success Rate
12/12 ratings generated profit
100%
Average Return
+37.09%
Copying Michael Ryskin's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +37.09% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DGX Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
0
0
0
Buy
7
11
5
7
10
Hold
7
12
8
8
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
23
13
15
15
In the current month, DGX has received 10 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. DGX average Analyst price target in the past 3 months is 4,351.92.
Each month's total comprises the sum of three months' worth of ratings.

DGX Financial Forecast

DGX Earnings Forecast

Next quarter’s earnings estimate for DGX is $49.94 with a range of $48.04 to $51.48. The previous quarter’s EPS was $54.63. DGX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year DGX has Performed in-line its overall industry.
Next quarter’s earnings estimate for DGX is $49.94 with a range of $48.04 to $51.48. The previous quarter’s EPS was $54.63. DGX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year DGX has Performed in-line its overall industry.

DGX Sales Forecast

Next quarter’s sales forecast for DGX is $53.00B with a range of $51.86B to $54.10B. The previous quarter’s sales results were $53.28B. DGX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year DGX has Performed in-line its overall industry.
Next quarter’s sales forecast for DGX is $53.00B with a range of $51.86B to $54.10B. The previous quarter’s sales results were $53.28B. DGX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year DGX has Performed in-line its overall industry.

DGX Stock Forecast FAQ

What is MX:DGX’s average 12-month price target, according to analysts?
Based on analyst ratings, Quest Diagnostics’s 12-month average price target is 4,351.92.
    What is MX:DGX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:DGX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Quest Diagnostics a Buy, Sell or Hold?
        Quest Diagnostics has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 0 sell ratings.
          What is Quest Diagnostics’s share price target?
          The average share price target for Quest Diagnostics is 4,351.92. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $4,639.84 ,and the lowest forecast is $3,851.95. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Quest Diagnostics?
            Quest Diagnostics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
              How can I buy shares of Quest Diagnostics?
              To buy shares of MX:DGX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.